Norwegian experts screen immunological reaction by AstraZeneca cause thrombosis

Norwegian experts have announced that they believe that the immunological reaction of the vaccine against AvidZeneca’s covid-19 is the cause of the thrombosis that afflicts three sanitizers in their countries.

The medical team of the University Hospital of Oslo, which analyzes these three cases, shares the controversial formula of AstraZeneca with the cases of thrombosis reported in various vacancies, which he provoked the suspension of the use of this drug in various European countries.

“We have a variety of hallucinations that can explain the clinical evolution of patients. These hallmarks respond to our hypothesis that patients should undergo an immunological response that provokes the formation of anticoagulants, which can be used to prevent it.” Holme, chief medical officer.

The tresjadores, todos menores de 50 años, fueron ingresados ​​el fin de semana kon un unus clinique quadrous quuslia una baja cantidad de sanguíneas plaques, coagulos en vasos sanguíneos pequños y grande y hemorragias, the application of the vacuna.

The Norwegian authorities will notify you on Monday of the day before one of them, a woman with no previous complaints, while in Denmark she has failed to be a minor for 60 years with perishable sins.

“There is no other possible explanation at the moment,” said Holme, chief nurse of the Norwegian hospital, who said he found specific antidotes that were also found in other cases with anterior and all causes.

Holme, who is investigating whether the tenien patients are being cared for by suspects, said he had no direct contact with the European Medicines Agency (EMA), that these juveniles should report the results of their investigations into the AstraZeneca vaccine.

Denmark is the first European country to suspend a week the use of the vaccine, a decision that has taken many European countries, including Norway, Germany, Spain, France and Italy.

Holme has no objection to his opinion on whether to ban the use of the vaccine in Norway and signal that this decision corresponds to the sanitary authorities.

.Source